R&D Views & Analysis | pharmaphorum

Monday 9 February 2026

Views & Analysis

R&D

Chris Moore from Veeva Systems interview with Nicole Raleigh

In conversation with Chris Moore: Declining HCP access

During the 10th anniversary of the Veeva R&D and Quality Summit, held in Madrid in June, web editor Nicole Raleigh sat down with Chris Moore, president of Europe for Veeva Systems, to d

R&D

Frantz Maignan and Grant Brock podcast

Sponsored

Tips for on-time tech transfers that stay on budget

When it comes to life sciences manufacturing, there's nothing quite so daunting as a tech transfer - moving a product from development to commercialisation, or to a new facility or CDMO, pr

R&D

laboratory work

Clinical development rates are falling - but it’s not all ba...

Over the past decade, a shift has been occurring in biopharma R&D.

R&D

connecting the dots in rare disease

Connecting the clinical, regulatory, and commercial dots for...

The path to rare disease product innovation involves interdependencies between clinical, regulatory, and commercial.

R&D

trend wave with Caroline Redecker and Jason Casarella pictured

Sponsored

Clinical trial trends and the rise of site networks

We've recently passed the midpoint of 2024, so it's a good time to check in on trends – in this case, trends in the clinical trial space.

R&D

cloud software and data

Sponsored

SK Life Science Leverages Smart, Efficient Solutions Across ...

When SK Life Science began, it tapped into healthcare providers, patients, and scientists t